Cargando…

Clinical Characteristics and Outcomes of Severe and Critical Patients With 2019 Novel Coronavirus Disease (COVID-19) in Wenzhou: A Retrospective Study

Information about severe cases of 2019 novel coronavirus disease (COVID-19) infection is scarce. The aim of this study was to report the clinical characteristics and outcomes of severe and critical patients with confirmed COVID-19 infection in Wenzhou city. In this single-centered, retrospective coh...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Song-Zan, Hong, Wan-dong, Lingjie-mao, Chenfeng-lin, Zhendong-fang, Pan, Jing-Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500473/
https://www.ncbi.nlm.nih.gov/pubmed/33015108
http://dx.doi.org/10.3389/fmed.2020.552002
_version_ 1783583868172894208
author Qian, Song-Zan
Hong, Wan-dong
Lingjie-mao,
Chenfeng-lin,
Zhendong-fang,
Pan, Jing-Ye
author_facet Qian, Song-Zan
Hong, Wan-dong
Lingjie-mao,
Chenfeng-lin,
Zhendong-fang,
Pan, Jing-Ye
author_sort Qian, Song-Zan
collection PubMed
description Information about severe cases of 2019 novel coronavirus disease (COVID-19) infection is scarce. The aim of this study was to report the clinical characteristics and outcomes of severe and critical patients with confirmed COVID-19 infection in Wenzhou city. In this single-centered, retrospective cohort study, we consecutively enrolled 37 RT-PCR confirmed positive severe or critical patients from January 28 to February 16, 2020 in a tertiary hospital. Outcomes were followed up until 28-day mortality. Fifteen severe and 22 critical adult patients with the COVID-19 infection were included. Twenty-six (68.4%) were men. Echocardiography data results suggest that normal or increased cardiac output and diastolic dysfunction are the most common manifestations. Compared with severe patients, critical patients were older, more likely to exhibit low platelet counts and high blood urea nitrogen, and were in hospital for longer. Most patients had organ dysfunction during hospitalization, including 11 (29.7%) with ARDS, 8 (21.6%) with acute kidney injury, 17 (45.9%) with acute cardiac injury, and 33 (89.2%) with acute liver dysfunction. Eighteen (48.6%) patients were treated with high-flow ventilation, 9 (13.8%) with non-invasive ventilation, 10 (15.4%) with invasive mechanical ventilation, 7 (18.9%) with prone position ventilation, 6 (16.2%) with extracorporeal membrane oxygenation (ECMO), and 3 (8.1%) with renal replacement therapy. Only 1 (2.7%) patient had died in the 28-day follow up in our study. All patients had bilateral infiltrates on their chest CT scan. Twenty-one (32.3%) patients presented ground glass opacity (GGO) with critical patients more localized in the periphery and the center. The mortality of critical patients with the COVID-19 infection is low in our study. Cardiac function was enhanced in the early stage and less likely to develop into acute cardiac injury, but most patients suffered with acute liver injury. The CT imaging presentations of COVID-19 in critical patients were more likely with consolidation and bilateral lung involvement.
format Online
Article
Text
id pubmed-7500473
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-75004732020-10-02 Clinical Characteristics and Outcomes of Severe and Critical Patients With 2019 Novel Coronavirus Disease (COVID-19) in Wenzhou: A Retrospective Study Qian, Song-Zan Hong, Wan-dong Lingjie-mao, Chenfeng-lin, Zhendong-fang, Pan, Jing-Ye Front Med (Lausanne) Medicine Information about severe cases of 2019 novel coronavirus disease (COVID-19) infection is scarce. The aim of this study was to report the clinical characteristics and outcomes of severe and critical patients with confirmed COVID-19 infection in Wenzhou city. In this single-centered, retrospective cohort study, we consecutively enrolled 37 RT-PCR confirmed positive severe or critical patients from January 28 to February 16, 2020 in a tertiary hospital. Outcomes were followed up until 28-day mortality. Fifteen severe and 22 critical adult patients with the COVID-19 infection were included. Twenty-six (68.4%) were men. Echocardiography data results suggest that normal or increased cardiac output and diastolic dysfunction are the most common manifestations. Compared with severe patients, critical patients were older, more likely to exhibit low platelet counts and high blood urea nitrogen, and were in hospital for longer. Most patients had organ dysfunction during hospitalization, including 11 (29.7%) with ARDS, 8 (21.6%) with acute kidney injury, 17 (45.9%) with acute cardiac injury, and 33 (89.2%) with acute liver dysfunction. Eighteen (48.6%) patients were treated with high-flow ventilation, 9 (13.8%) with non-invasive ventilation, 10 (15.4%) with invasive mechanical ventilation, 7 (18.9%) with prone position ventilation, 6 (16.2%) with extracorporeal membrane oxygenation (ECMO), and 3 (8.1%) with renal replacement therapy. Only 1 (2.7%) patient had died in the 28-day follow up in our study. All patients had bilateral infiltrates on their chest CT scan. Twenty-one (32.3%) patients presented ground glass opacity (GGO) with critical patients more localized in the periphery and the center. The mortality of critical patients with the COVID-19 infection is low in our study. Cardiac function was enhanced in the early stage and less likely to develop into acute cardiac injury, but most patients suffered with acute liver injury. The CT imaging presentations of COVID-19 in critical patients were more likely with consolidation and bilateral lung involvement. Frontiers Media S.A. 2020-09-04 /pmc/articles/PMC7500473/ /pubmed/33015108 http://dx.doi.org/10.3389/fmed.2020.552002 Text en Copyright © 2020 Qian, Hong, Lingjie-mao, Chenfeng-lin, Zhendong-fang and Pan. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Qian, Song-Zan
Hong, Wan-dong
Lingjie-mao,
Chenfeng-lin,
Zhendong-fang,
Pan, Jing-Ye
Clinical Characteristics and Outcomes of Severe and Critical Patients With 2019 Novel Coronavirus Disease (COVID-19) in Wenzhou: A Retrospective Study
title Clinical Characteristics and Outcomes of Severe and Critical Patients With 2019 Novel Coronavirus Disease (COVID-19) in Wenzhou: A Retrospective Study
title_full Clinical Characteristics and Outcomes of Severe and Critical Patients With 2019 Novel Coronavirus Disease (COVID-19) in Wenzhou: A Retrospective Study
title_fullStr Clinical Characteristics and Outcomes of Severe and Critical Patients With 2019 Novel Coronavirus Disease (COVID-19) in Wenzhou: A Retrospective Study
title_full_unstemmed Clinical Characteristics and Outcomes of Severe and Critical Patients With 2019 Novel Coronavirus Disease (COVID-19) in Wenzhou: A Retrospective Study
title_short Clinical Characteristics and Outcomes of Severe and Critical Patients With 2019 Novel Coronavirus Disease (COVID-19) in Wenzhou: A Retrospective Study
title_sort clinical characteristics and outcomes of severe and critical patients with 2019 novel coronavirus disease (covid-19) in wenzhou: a retrospective study
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500473/
https://www.ncbi.nlm.nih.gov/pubmed/33015108
http://dx.doi.org/10.3389/fmed.2020.552002
work_keys_str_mv AT qiansongzan clinicalcharacteristicsandoutcomesofsevereandcriticalpatientswith2019novelcoronavirusdiseasecovid19inwenzhouaretrospectivestudy
AT hongwandong clinicalcharacteristicsandoutcomesofsevereandcriticalpatientswith2019novelcoronavirusdiseasecovid19inwenzhouaretrospectivestudy
AT lingjiemao clinicalcharacteristicsandoutcomesofsevereandcriticalpatientswith2019novelcoronavirusdiseasecovid19inwenzhouaretrospectivestudy
AT chenfenglin clinicalcharacteristicsandoutcomesofsevereandcriticalpatientswith2019novelcoronavirusdiseasecovid19inwenzhouaretrospectivestudy
AT zhendongfang clinicalcharacteristicsandoutcomesofsevereandcriticalpatientswith2019novelcoronavirusdiseasecovid19inwenzhouaretrospectivestudy
AT panjingye clinicalcharacteristicsandoutcomesofsevereandcriticalpatientswith2019novelcoronavirusdiseasecovid19inwenzhouaretrospectivestudy